Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.
Chaillon, Antoine
Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection. [electronic resource] - PloS one 2012 - e44163 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0044163 doi
Amino Acid Sequence
Analysis of Variance
Antibodies, Neutralizing--blood
Bayes Theorem
Evolution, Molecular
HIV Envelope Protein gp120--genetics
HIV Infections--blood
HIV-1--genetics
Humans
Likelihood Functions
Markov Chains
Models, Genetic
Monte Carlo Method
Phylogeny
Selection, Genetic
Sensitivity and Specificity
Sequence Analysis, DNA
Survivors
Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection. [electronic resource] - PloS one 2012 - e44163 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0044163 doi
Amino Acid Sequence
Analysis of Variance
Antibodies, Neutralizing--blood
Bayes Theorem
Evolution, Molecular
HIV Envelope Protein gp120--genetics
HIV Infections--blood
HIV-1--genetics
Humans
Likelihood Functions
Markov Chains
Models, Genetic
Monte Carlo Method
Phylogeny
Selection, Genetic
Sensitivity and Specificity
Sequence Analysis, DNA
Survivors